# TransMolecular

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/transmolecular

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Total disclosed funding: $42M
- Latest round: Series C (Mar 1, 2004)
- Investors on record: 14

## About

TransMolecular is a biotechnology company based in Massachusetts, US. It focuses on developing and commercializing novel and proprietary drugs to diagnose and treat human cancers having inadequate pharmaceutical alternatives.

## Funding rounds

- Series C, Mar 1, 2004, $33M — Pacific Horizon Ventures, Tullis Health Investors, TVM Capital Life Science, Easton Capital Investment Group, Cogene Ventures, Aperture Venture Partners, Diamond Capital, Oakwood Medical Investors, POSCO BioVentures, Greer Capital, Global Biomedical Partners, President Life Sciences Co. Ltd., Lumira Ventures
- Series B, Sep 14, 2000, $9M — Pacific Horizon Ventures, Tullis Health Investors, TVM Capital Life Science, Portrush Group, President Life Sciences Co. Ltd.
- Series A, Jan 1, 1997 — Tullis Health Investors

## Investors

- Tullis Health Investors (https://capitalatlas.ai/funds/tullis-health-investors) — Series A, Series B, Series C
- Pacific Horizon Ventures (https://capitalatlas.ai/funds/pacific-horizon-ventures) — Series B, Series C
- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series B, Series C
- Portrush Group — Series B
- President Life Sciences Co. Ltd. — Series B, Series C
- Easton Capital Investment Group (https://capitalatlas.ai/funds/easton-capital-investment-group) — Series C
- Cogene Ventures (https://capitalatlas.ai/funds/cogene-ventures) — Series C
- Aperture Venture Partners (https://capitalatlas.ai/funds/aperture-venture-partners) — Series C
- Diamond Capital — Series C
- Oakwood Medical Investors (https://capitalatlas.ai/funds/oakwood-medical-investors) — Series C
- POSCO BioVentures (https://capitalatlas.ai/funds/posco-bioventures) — Series C
- Greer Capital (https://capitalatlas.ai/funds/greer-capital) — Series C
- Global Biomedical Partners — Series C
- Lumira Ventures (https://capitalatlas.ai/funds/lumira-ventures) — Series C